Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stran & Company (SWAG) Gains from Investment Securities (2021 - 2025)

Historic Gains from Investment Securities for Stran & Company (SWAG) over the last 5 years, with Q3 2025 value amounting to $1.4 million.

  • Stran & Company's Gains from Investment Securities rose 230.9% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 230.9%. This contributed to the annual value of $1.4 million for FY2024, which is 612.04% down from last year.
  • As of Q3 2025, Stran & Company's Gains from Investment Securities stood at $1.4 million, which was up 230.9% from $1.4 million recorded in Q2 2025.
  • Stran & Company's 5-year Gains from Investment Securities high stood at $10.7 million for Q4 2021, and its period low was -$38000.0 during Q4 2024.
  • For the 5-year period, Stran & Company's Gains from Investment Securities averaged around $2.0 million, with its median value being $1.5 million (2022).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 8597.56% in 2022, then soared by 230.9% in 2025.
  • Stran & Company's Gains from Investment Securities (Quarter) stood at $10.7 million in 2021, then tumbled by 85.98% to $1.5 million in 2022, then increased by 3.96% to $1.6 million in 2023, then plummeted by 102.43% to -$38000.0 in 2024, then soared by 3811.84% to $1.4 million in 2025.
  • Its Gains from Investment Securities stands at $1.4 million for Q3 2025, versus $1.4 million for Q2 2025 and $1.4 million for Q1 2025.